Ergoteles’s Transmedics TMDX Stock Holding History

Ergoteles’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-10,000	Closed	-$332K	–	1661
2021 Q2	$332K	Buy	+10,000	New	+$277K	0.01%	1021

Other funds holding TMDX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SCP

Sandhill Capital Partners Buffalo, New York $1.23B AUM 13.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KXA

KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ergoteles's TMDX Position: Q3 2021 in Review

Ergoteles sold out of Transmedics (TMDX) in Q3 2021, closing a stake of 10,000 shares — an estimated $332K sold.

Ergoteles first reported a position in TMDX in Q2 2021 and held it in 1 quarter. The position peaked at $332K in Q2 2021. 120 funds tracked by Wall St. Rank hold TMDX as of Q3 2021.

Ergoteles reported no remaining Transmedics position as of Q3 2021 after selling out during the quarter.
Ergoteles sold 10,000 Transmedics shares in Q3 2021, an estimated $332K.
Ergoteles first reported a position in Transmedics in Q2 2021 and held it in 1 quarter.
Ergoteles's Transmedics position peaked at $332K in Q2 2021.
120 funds tracked by Wall St. Rank held Transmedics as of Q3 2021.

Based on Ergoteles's 13F filing for Q3 2021, filed 15 Nov 2021.